Alnajashi, Hind. “Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment”. Journal of Contemporary Medical Sciences 11, no. 4 (August 26, 2025). Accessed May 19, 2026. https://jocms.org/index.php/jcms/article/view/1916.